Vantage Investment Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$52.8M |
| 2 |
Centene
CNC
|
+$28.4M |
| 3 |
Elanco Animal Health
ELAN
|
+$23.8M |
| 4 |
Humana
HUM
|
+$23.4M |
| 5 |
Electronic Arts
EA
|
+$15.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$41.8M |
| 2 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$7.69M |
| 3 |
Visa
V
|
+$5.88M |
| 4 |
UBS Group
UBS
|
+$4.93M |
| 5 |
Mastercard
MA
|
+$4.46M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.77% |
| 2 | Technology | 21.25% |
| 3 | Financials | 16.28% |
| 4 | Communication Services | 11.31% |
| 5 | Consumer Discretionary | 6.77% |
Similar funds
Vantage Investment Partners's Q3 2019 Portfolio in Review
As of Q3 2019, Vantage Investment Partners held 93 positions worth $962M, up 10% from $875M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Vantage Investment Partners deployed $95.8M of net new capital in Q3 2019, opening 6 new positions and adding to 49 existing holdings. Its largest new stake was Elanco Animal Health: 794,500 shares worth $21.1M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $41.8M trimmed.
- Vantage Investment Partners's largest Q3 2019 buy was Elanco Animal Health: 794,500 shares worth $21.1M.
- Vantage Investment Partners added most to UnitedHealth in Q3 2019, an estimated $52.8M increase.
- Vantage Investment Partners's biggest Q3 2019 reduction was Walt Disney, cutting an estimated $41.8M.
- Vantage Investment Partners fully exited UBS Group in Q3 2019, selling an estimated $4.93M.
- Vantage Investment Partners's ten largest holdings make up 47% of its $962M portfolio in Q3 2019.
- Vantage Investment Partners opened 6 new positions and closed 7 in Q3 2019.
- Vantage Investment Partners's portfolio value rose 10% quarter-over-quarter to $962M.
Based on Vantage Investment Partners's 13F filing for Q3 2019, filed 24 Oct 2019.